News

BioStat® Research
& Development Centre

2024 2023 2022 older
Biostat 6th consecutive year as research and development center
18
October
2024
Biostat 6th consecutive year as research and development center
The Minister of Development and Technology has decided to maintain Biostat's status as a research and development...
Study on generalized myasthenia gravis for AstraZeneca
09
October
2024
Study on generalized myasthenia gravis for AstraZeneca
The Biostat Research and Development Center will carry out another project in collaboration with AstraZeneca. T...
Study of new solutions in surgery for Corza Medical
26
August
2024
Study of new solutions in surgery for Corza Medical
The Biostat Research and Development Center has signed an agreement with Corza Medical to conduct a PASS study in the...
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
21
August
2024
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
Marek Kluszczyński, MD, who specializes in the rehabilitation of children and adolescents, has published a scientific...
Biostat will conduct a medical experiment for Stallergenes Greer
17
July
2024
Biostat will conduct a medical experiment for Stallergenes Greer
Biostat Research and Development Center has signed an agreement with a pharmaceutical company Stallergenes Greer to c...
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
09
July
2024
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
The innovative CoolCryo® system for cardiac cryoablation, for which Biostat is conducting a clinical trial,...
Biostat will conduct a non-interventional study for Adamed Pharma
27
June
2024
Biostat will conduct a non-interventional study for Adamed Pharma
A non-interventional study among cardiology patients - this is a new field of cooperation between the Biostat R...
Biostat listed in the Forbes ranking
21
May
2024
Biostat listed in the Forbes ranking
For another year in a row, Biostat Research and Development Center has been recognized in the ranking of the most dyn...
Biostat and MSD Polska collaborate on lung cancer study
16
May
2024
Biostat and MSD Polska collaborate on lung cancer study
The Biostat Research and Development Centre starts cooperation with the MSD Polska pharmaceutical company. ...
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
20
December
2018
On-going collaboration with Celon Pharma
20
December
2018

On-going collaboration with Celon Pharma

The Customer needs have always been prioritized at BioStat. This is the basic for the philosophy our company derives from.

Our company receives many inquiries for collaboration every day as far as clinical trials are concerned. The institutions that reach out to us the most are pharmaceutical and biotechnological companies, institutes, medical centres, CRO’s, hospitals, freelancers indicating prospective scope of cooperation. The interest in our services is constantly increasing making us even more attractive business partner. 

The cooperation model we establish is different each time, yet it mostly focuses on our authorial eCRF.bizTM system, that becomes a gold standard in research not only on the Polish market. Being given so many positive recommendations, our company earns and builds its advantage over the competition. At the same time, large interest in BioStat services gives us the privilege to decide which company we would like to develop the collaboration with and work further.

The effective dialogue and subsequent prompt feedback to the customer demands as well as flexibility results in yet further contracts. The growth of clinical trials sector requires us to constantly develop our research tools.

Every project becomes a source of inspiration for future development, and we as BioStat – the company with  aspirations, would like to set trends and good practices in gathering and maintaining data.

Celon Pharma – the company that consequently enlarges the portfolio of innovative medicine has invited us to another collaboration. We all agree on the fact that a strong business partner such as our company is the crucial element that results in overall research success.

 

> Learn more about Biostat's clinical research services

Copyright© 2023 Biostat